190 related articles for article (PubMed ID: 1981724)
1. Biotransformation of sufentanil in liver microsomes of rats, dogs, and humans.
Lavrijsen K; Van Houdt J; Van Dyck D; Hendrickx J; Lauwers W; Hurkmans R; Bockx M; Janssen C; Meuldermans W; Heykants J
Drug Metab Dispos; 1990; 18(5):704-10. PubMed ID: 1981724
[TBL] [Abstract][Full Text] [Related]
2. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Swysen E; Thijssen J; Timmerman P; Woestenborghs R; Heykants J
Drug Metab Dispos; 1987; 15(6):905-13. PubMed ID: 2893720
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of alfentanil by isolated hepatocytes of rat and dog.
Lavrijsen K; Van Houdt J; Meuldermans W; Knaeps F; Hendrickx J; Lauwers W; Hurkmans R; Heykants J
Xenobiotica; 1988 Feb; 18(2):183-97. PubMed ID: 3131971
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
5. Comparative metabolism of flunarizine in rats, dogs and man: an in vitro study with subcellular liver fractions and isolated hepatocytes.
Lavrijsen K; van Houdt J; van Dyck D; Hendrickx J; Bockx M; Hurkmans R; Meuldermans W; Le Jeune L; Lauwers W; Heykants J
Xenobiotica; 1992 Jul; 22(7):815-36. PubMed ID: 1455902
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs.
Andersson SH; Lindgren A; Postlind H
Drug Metab Dispos; 1998 Jun; 26(6):528-35. PubMed ID: 9616187
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of a new anticancer agent, 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosil)5H-indolo+ ++[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), in mice, rats, dogs, and humans.
Takenaga N; Hasegawa T; Ishii M; Ishizaki H; Hata S; Kamei T
Drug Metab Dispos; 1999 Feb; 27(2):213-20. PubMed ID: 9929505
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
Vyas KP; Kari PH; Prakash SR; Duggan DE
Drug Metab Dispos; 1990; 18(2):218-22. PubMed ID: 1971576
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of felodipine in liver microsomes from rat, dog, and man.
Bäärnhielm C; Backman A; Hoffmann KJ; Weidolf L
Drug Metab Dispos; 1986; 14(5):613-8. PubMed ID: 2876870
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions.
Kedderis GL; Argenbright LS; Walsh JS; Smith JL; Stearns RA; Arison BA; Miwa GT
Drug Metab Dispos; 1989; 17(6):606-11. PubMed ID: 2575495
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of the anti-angiogenic compound SU5416.
Antonian L; Zhang H; Yang C; Wagner G; Shawver LK; Shet M; Ogilvie B; Madan A; Parkinson A
Drug Metab Dispos; 2000 Dec; 28(12):1505-12. PubMed ID: 11095590
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
Erve JC; Vashishtha SC; DeMaio W; Talaat RE
Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism of nefiracetam by liver microsomes from rats, dogs and monkeys.
Fujimaki Y; Sudo K; Hakusui H
Arzneimittelforschung; 1995 Jul; 45(7):748-52. PubMed ID: 8573215
[TBL] [Abstract][Full Text] [Related]
15. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
[TBL] [Abstract][Full Text] [Related]
16. The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice.
Dekant W; Assmann M; Urban G
Toxicol Appl Pharmacol; 1995 Dec; 135(2):200-7. PubMed ID: 8545828
[TBL] [Abstract][Full Text] [Related]
17. [In vitro comparison of thienorphine metabolism in liver microsomes of human, Beagle dog and rat].
Deng JT; Zhuang XM; Li H
Yao Xue Xue Bao; 2010 Jan; 45(1):98-103. PubMed ID: 21351457
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
Aprile S; Del Grosso E; Tron GC; Grosa G
Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
[TBL] [Abstract][Full Text] [Related]
19. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
Remmel RP; Crews BC; Kozak KR; Kalgutkar AS; Marnett LJ
Drug Metab Dispos; 2004 Jan; 32(1):113-22. PubMed ID: 14709628
[TBL] [Abstract][Full Text] [Related]
20. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
